Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice

OBJECTIVE: Diabetic cardiomyopathy (DCM), characterized by cardiomyopathy with the absence of coronary artery disease, hypertension, and valvular heart disease in patients with diabetes, significantly increases the risk of heart failure. Galectin-3 (Gal-3) has been shown to regulate cardiac inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ning, Zhu, Liuyan, Huang, Bingwu, Xiang, Wenjun, Zhao, Xuyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086782/
https://www.ncbi.nlm.nih.gov/pubmed/35557520
http://dx.doi.org/10.3389/fcvm.2022.868372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086782/
https://www.ncbi.nlm.nih.gov/pubmed/35557520
http://dx.doi.org/10.3389/fcvm.2022.868372

Ejemplares similares